Join Europe's most influential cell and gene therapy innovators as they navigate regulatory challenges, address manufacturing hurdles, and accelerate therapeutic development beyond CAR-T and AAV therapies. Connect with decision-makers from leading pharmaceutical organisations, innovative CGT biotech companies, research centres and emerging start-ups collectively tackling the pressing challenges in scaling production and improving patient access to advanced therapies throughout Europe.
